ArticleBreast cancer research : BCR2026
TTPAL inhibits the progression of breast cancer and reprograms tumor-associated macrophages by inhibiting JAK2/STAT3 signaling pathway.
Lingfang Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.